Patient-specific immunoglobulin idiotype (Id)

The patient-specific immunoglobulin idiotype is a unique tumor-specific antigen found on the surface of malignant B-cells in lymphoproliferative disorders (Kwak et al., 1992, NEJM). It consists of the unique amino acid sequences within the variable regions (V-regions) of the heavy and light chains of the immunoglobulin molecule, which are generated during B-cell development through V(D)J recombination (Levy, 2010, Curr Top Microbiol Immunol). Because each B-cell clone produces a unique idiotype, it serves as an ideal target for personalized immunotherapy, specifically idiotype vaccines (Schuster et al., 2011, JCO). These vaccines are custom-manufactured for each patient by isolating the tumor-specific idiotype and conjugating it to an immunogenic carrier protein, such as Keyhole Limpet Hemocyanin (KLH), to overcome self-tolerance (Bendandi et al., 1999, Nat Med). The primary biological function of the idiotype in this context is its role as the B-cell receptor (BCR), which mediates signal transduction and antigen recognition. Therapeutic strategies, such as Dasiprotimut-T, aim to induce a host immune response against the malignant clone. Despite the high specificity of this target, clinical development has faced significant hurdles, including the requirement for individualized production and the need for potent adjuvants to elicit a robust clinical response (Inoges et al., 2006, JCO).

Other names

Tumor-specific idiotypeB-cell idiotypeImmunoglobulin variable regionId antigenClonal idiotype

Active immunotherapy designed to stimulate the patient's immune system to recognize and destroy malignant B-cells by targeting the unique variable region of the clonal surface immunoglobulin.